Skip to main content
Equibles
SPRY logo

SPRY · ARS Pharmaceuticals, Inc. · Short Interest

Track SPRY — free

Use SPRY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SPRY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.22 -0.17 (-3.15%) At close · Sep 9
Russell 2000 member Rebalance outlook locked
Market Cap
$558.89M
Shares
99.45M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Pull short interest history through the short interest API or MCP →

SPRY Latest Reported Short Interest

FINRA reported 22,952,291 SPRY shares sold short as of the August 14, 2026 settlement date, an increase of 1,500,755 shares. Days to cover was 11.03 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

SPRY Short Interest Forecast

Equibles' model estimates 22,929,493 shares sold short for the August 31, 2026 settlement, -0.1% versus the latest reported position, with a likely range of 20,983,520 to 24,863,092 shares. This model prediction uses FINRA data through August 31, 2026; FINRA's official release is expected September 10, 2026.

Model estimate

Expected Aug 31 short interest

as of Aug 31 Low confidence 48% chance it rises
22,929,493 -0.1% vs reported
Likely range 20,983,520 to 24,863,092 The latest estimate appears in the chart below. Official release expected Sep 10. Methodology
Short Squeeze Score
79/100
Short interest 23.1% of shares — P99 Days to cover 11.0 — P91 Price vs VWAP -22.9% — P10 Short-volume trend +20.5% — P93 Short interest change +7.0% — P72 Worst FTD 0.10% of shares — P83

Positioning score 79.0 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-08-14). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-09-10 03:07 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-09-15 Scheduled
    FINRA publishes Sep 24
    		 — — — —
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 22,952,291 21,451,536 +1,500,755 11.03
    2026-07-31 21,451,536 22,669,317 -1,217,781 7.78
    2026-07-15 22,669,317 21,733,764 +935,553 15.30
    2026-06-30 21,733,764 23,090,842 -1,357,078 8.55
    2026-06-15 23,090,842 25,495,252 -2,404,410 17.61
    2026-05-29 25,495,252 25,912,002 -416,750 14.08
    2026-05-15 25,912,002 26,192,671 -280,669 13.30
    2026-04-30 26,192,671 26,764,648 -571,977 15.13
    2026-04-15 26,764,648 25,341,296 +1,423,352 21.22
    2026-03-31 25,341,296 23,719,421 +1,621,875 13.89
    2026-03-13 23,719,421 22,750,867 +968,554 17.90
    2026-02-27 22,750,867 22,236,209 +514,658 32.31
    2026-02-13 22,236,209 21,399,226 +836,983 18.41
    2026-01-30 21,399,226 20,224,758 +1,174,468 15.19
    2026-01-15 20,224,758 20,509,054 -284,296 9.35
    2025-12-31 20,509,054 21,588,277 -1,079,223 14.71
    2025-12-15 21,588,277 20,664,949 +923,328 12.42
    2025-11-28 20,664,949 20,140,227 +524,722 8.01
    2025-11-14 20,140,227 19,756,847 +383,380 8.37
    2025-10-31 19,756,847 18,964,276 +792,571 11.89
    2025-10-15 18,964,276 21,690,186 -2,725,910 7.27
    2025-09-30 21,690,186 21,583,515 +106,671 8.39
    2025-09-15 21,583,515 21,041,326 +542,189 6.10

    Full FINRA short interest reporting calendar

    Showing 1–23 of 23 settlements
    Key facts CIK 1671858 CUSIP 82835W108 13F (30d) 134 filings 134 filers Visit website Investor relations